UNITEDHEALTH GROUP INC

UnitedHealth eliminates prior‑authorization for dozens of services, cutting admin costs and speeding care—boosting coverage ease and setting a new industry benchmark.

Explore UnitedHealth Group’s resilient U.S. healthcare strategy: diverse revenue, strong liquidity, and tech-driven growth—while navigating data privacy rules and value‑based care trends.

UnitedHealth Group Q2 2026: revenue beats forecasts, EPS up 9%, medical cost ratio drops to 68.5%. Early‑intervention behavioral programs boost margins and drive future growth.

Explore UnitedHealth’s $1.5B AI push, Tepper’s exit impact, and robust governance – a deep dive into how technology and transparency drive long‑term value in health‑care.

UnitedHealth Group’s Patrick Conway plans to sell 1,169 shares, a rule‑compliant insider move that expands float but won’t move the stock price.

UnitedHealth Group’s stock slides amid U.S.-Iran tensions, rising oil, and a high‑profile double‑jeopardy case—how legal and geopolitical risks shape its future.

UnitedHealth faces legal fallout after its CEO’s murder; first guilty plea, potential federal sentencing, and stock impact revealed in detailed corporate report.

UnitedHealth faces federal lawsuit over 2022 Change Healthcare acquisition, citing data breach, audit shutdown, and Medicare billing claims. Learn how the company’s response and insider trading disclosure impact investor confidence.

UnitedHealth’s shares fall as oil prices rise and geopolitical tensions spike—showing how macro risks, not company performance, drive the healthcare market.

UnitedHealth Group tops Q2 expectations with strong Medicare Advantage gains, tight cost control, and doubled share‑repurchase—boosting profit outlook and shareholder value.